CRO Stocks Slip as Key Players Post Losses
On August 26, the CRO sector experienced a downturn, with several constituent stocks recording notable declines. Yinuosi fell 5.97%, Kanglongcheng dropped 5.21%, and Yiqiao Shenzhou declined 5.01%. Other companies, including Chengda Pharmaceutical, Bide Pharmaceutical, and Boji Pharmaceutical, each fell more than 4%. The sector-wide weakness reflected cautious trading sentiment, with losses confirmed at the close.
The CRO (Contract Research Organization) sector experienced a downturn during trading on August 26, with multiple constituent stocks recording significant declines. Yinuosi fell 5.97%, Kanglongcheng dropped 5.21%, and Yiqiao Shenzhou declined 5.01%. Chengda Pharmaceutical, Bide Pharmaceutical, and Boji Pharmaceutical each fell more than 4%.
The decline affected numerous companies within the sector, as related stocks showed weakness during the day's trading, reflecting cautious overall market sentiment. By the close, the decline figures for the aforementioned stocks had been confirmed, with other constituent stocks also impacted to varying degrees.